Identification and Evaluation of Endogenous Markers for the Assessment of CYP3A Activity Using Metabolomics
Clinical trial NCT01215214 · COMPLETED
Trial details
- NCT number
- NCT01215214
- Sponsor
- Seoul National University Hospital
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2010-10-01
- Primary completion
- 2010-11-01
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.